AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 13 filers reported holding AYALA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,944 | -70.8% | 56,900 | -30.5% | 0.00% | -50.0% |
| Q3 2022 | $82,000 | -7.9% | 81,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $89,000 | -72.7% | 81,900 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $326,000 | -50.9% | 81,900 | +5.0% | 0.01% | -50.0% |
| Q4 2021 | $664,000 | +10.5% | 78,000 | +47.2% | 0.01% | +9.1% |
| Q3 2021 | $601,000 | +84.4% | 53,000 | +65.8% | 0.01% | +83.3% |
| Q2 2021 | $326,000 | -14.7% | 31,962 | -8.7% | 0.01% | -14.3% |
| Q1 2021 | $382,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 2,153,273 | $862 | 0.02% |
| Psagot Value Holdings Ltd. / (Israel) | 36,232 | $14 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 56,900 | $23,944 | 0.00% |
| Ameliora Wealth Management Ltd. | 750 | $316 | 0.00% |
| Renaissance Technologies | 53,600 | $21 | 0.00% |
| Avantax Planning Partners, Inc. | 10,000 | $4,001 | 0.00% |
| UBS Group AG | 1,010 | $404 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,596 | $4 | 0.00% |
| MORGAN STANLEY | 13,931 | $5,574 | 0.00% |